more generally) often seems to presuppose that defendants in patent cases are in fact engaged in copying. Similarly, the outcome of public policy debates over patent reform may well turn on the perception of patent infringers as either bad actors or as innocent businesspeople who accidentally ran afoul of a patent.
Unfortunately, no one seems to know whether patent infringement defendants are in fact unscrupulous copyists or independent developers. In this paper, we seek to answer that question. Because copying is not an element of any patent cause of action, courts do not normally make explicit findings as to whether defendants have copied. Instead, we turn to a variety of proxies to try to identify the subset of cases in which copying is alleged or proven. We look both at the allegations made in a random sample of complaints and at the treatment of copying in recent reported decisions. We find that a surprisingly small percentage of patent cases involve even allegations of copying, much less proof of copying. Copying in patent law seems to be the exception, not the rule.
In Part I, we briefly discuss the legal significance of copying in patent law. In Part II, we identify the sources of our data and report our results. Finally, in Part III we discuss some policy implications of these results.
I. Copying's Current Place in Patent Doctrine
One of the most significant differences between patent law and other areas of intellectual property is that copying is irrelevant to the determination of infringement. another inventor. 15 The second conceiver can even be the first to put the invention to actual use and still be considered an infringer. 16 The lack of a copying requirement for liability places patent law in sharp contrast with copyright and trade secret law. Copyright law, as its name connotes, requires an individual to copy the protected work to be found liable. 17 While doctrines such as subconscious copying potentially remove the state of mind from the copying requirement, 18 actual copying is still a fundamental first step to determining copyright infringement.
19
Trade secret law is similar, requiring an individual to misappropriate the trade secret to be held liable. Misappropriation occurs when the trade secret is obtained 15 35 U.S.C. § 271(g) (defining the standard for determining priority between two inventors of the same technology); Cooper v. Goldfarb, 154 F.3d 1321, 1327 (Fed. Cir. 1998) (articulating the standard in reverse, noting that "priority of invention goes to the first party to reduce an invention to practice unless the other party can show that it was the first to conceive of the invention and that it exercised reasonable diligence in later reducing that invention to practice"); Merges & Duffy, supra note __, at 440-41. Reduction to practice is established by either actually implementing the invention or filing a patent application. See Medichem, S.A. v. Rolabo, S.L., 437 F.3d 1157, 1169 (Fed. Cir. 2006 ). An actual reduction to practice that has been "abandoned, suppressed, or concealed, does not count for priority purposes. See 35 U.S.C. § 271(g). 16 Again, this holds true as long as the first conceiver is diligent from the "time prior to the conception by the other." 35 U.S.C. § 271(g). 17 See Arnstein v. Porter, 154 F.2d 464, 468-69 (2d Cir. 1946). Some circuits allow copying to be established by "striking similarity" between the protected work and infringing works, even if there is no evidence that the alleged infringer had any access to the copyrighted work. Gaste v. Kaiserman, 863 F.2d 1061, 1067-68 (2d Cir.1988 ). Under such a test, copying is arguably not required to establish copyright infringement. However, the rationale for relying solely on striking similarity is that such evidence "preclude[s] the possibility of independent creation." Ferguson v. NBC, Inc., 584 F.2d 111, 113 (5th Cir. 1978). Thus, copying is still established, essentially by inference. 18 See ABKCO Music, Inc. v. Harrisongs Music, Ltd., 722 F.2d 988, 998-99 & n. 12 (2d Cir. 1983) (finding liability even though the copying was subconscious and without intent). 19 See Ty, Inc. v. GMA Accessories, Inc., 132 F.3d 1167, 1169 (7th Cir. 1997) ("The Copyright Act forbids only copying; if independent creation results in an identical work, the creator of that work is free to sell it.").
through improper means or through a breach of confidence. 20 Either trigger for liability entails a "copying" of the trade secret. The infringer obtains the information from someone else-in most cases the trade secret's creator. 21 By contrast, independent creation of the information, through normal means or reverse engineering, is a complete defense against a trade secret allegation.
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Trademark law occupies a middle ground. Trademark infringement is based upon a finding of likely consumer confusion, which can occur without copying of the mark by the defendant. But intent to copy or deceive is one of the factors courts use in deciding consumer confusion, 23 and recent work by Barton Beebe has found that in fact evidence of intent is the most significant factor predicting a finding of trademark infringement.
24
So as a practical matter trademark infringement usually involves copying, or at least awareness of the plaintiff's mark. While copying isn't necessary for infringement, the existence of copying is not completely irrelevant in patent law. Many doctrines outside of the initial determination of infringement consider whether the alleged infringer or a third party has copied the patented technology. Some patent theory assumes, as a precondition, that others will, in essence, copy the patented technology. Finally, much of the rhetoric used by courts and commentators when discussing patent infringement invokes the concepts of a copier and copying when identifying the infringer and describing her actions.
B. Copying Plays a Role in Other Patent Doctrines

Copying as an Element of Specific Patent Doctrines
Whether a finding of patent infringement was the result of copying is relevant to the question of willful infringement and the accompanying enhancement of damages. finding that the infringement wasn't willful. 29 Notably, while copying is evidence of willful infringement, copying is not required to prove willful infringement. 30 Nor does evidence of copying, by itself, mean the infringement is willful.
31
Copying is also relevant to the issue of patent validity as a secondary consideration of nonobviousness. 32 Copying of the patented invention by the infringer or a third party is seen by patent law as an indicator that the invention is nonobvious. 33 The rationale is that a competitor engages in such copying only if they need a solution to the problem the invention addresses and they cannot come up with one on their own. That rationale is open to question, however. A company may copy an invention not because it had no choice, but because it thought the invention was unpatented or unpatentable, and therefore free to be used without need for reinvention. 35 See Cotropia, supra note __, at 32. of these assumption from the existence of copying are indicators that the invention meets the nonobviousness requirement and is worthy of patent protection. 36 Third, copying is relevant to some claims for indirect infringement. Specifically, the Federal Circuit has made it clear that a defendant is not liable for inducing infringement by another unless it intended that the conduct it induced infringe a known patent.
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While this doesn't necessarily involve copying -a defendant might independently develop a technology, then learn of a patent covering it, and still encourage another to infringe that patent -the fact that inducement requires both knowledge of the patent and intent to encourage infringement means that inducement is more likely than ordinary infringement cases to involve allegations of copying.
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Finally, as an exception to the general rule that copying is irrelevant to the question of liability, an accusation of infringement under 35 U.S.C. § 271(e)(2)(A) necessarily involve acts of copying. Section 271(e)(2)(A) allows a patent holder to sue a generic drug manufacturer who files an abbreviated new drug application ("ANDA") that contains a paragraph 4 certification. 39 Such a certification alleges that the previously approved drug for which ANDA pertains is covered by patents that are invalid or will not be infringed by the generic drug. 40 In order to file a proper and successful ANDA, the 36 See id. (concluding that copying provides second-order evidence that the technology gap between the prior art and the invention is such that patent protection is warranted 40 See 21 U.S.C. § 355(j)(2)(A)(vii)(IV) (describing the content of a paragraph IV certification).
generic drug manufacturer must "copy" the original drug-the generic's active ingredient must be the bioequivalent of the listed drug. 41 These set of facts that give rise to a § 271(e)(2) allegation of infringement necessarily mean that the ANDA filer and generic drug producer have copied the patent holder's technology.
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It does not, however, necessarily mean that the patented invention was copied; the patent might cover something other than the active ingredient to which the generic is bioequivalent. But generally ANDA cases involve copying.
Copying as a Foundation for Particular Patent Theories
A number of patent theories also assume that others engage in some level of copying of the patent. The idea that a patent constitutes a bargain with the public, in which the patentee gets exclusivity for a limited time in exchange for giving the public information about the invention, presupposes that companies will read and learn from the patent in order to copy the invention (albeit after the patent has expired). The improvement and design-around theories assume that one of the patent law's benefits is that others reference the patent document and the technology it describes in order to either build upon the patented technology described or create competing, non-infringing alternatives. A level of copying is also assumed in the theory behind the doctrine of 41 An ANDA is proper only if the generic drug's active ingredient is the "bioequivalent" of the already approved drug. equivalents. One view of that doctrine is that it is meant to catch the "unscrupulous copyist" who has set out to copy the patented technology and makes a minor change in order to avoid infringement via a technicality.
a. The Disclosure Bargain and Improvement Theory
The improvement theory of patent law describes patenting as a mechanism to both assist and prompt others to develop improvements to the already patented technology.
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The patent disclosure, which is required to be enabling, provides technical information about the claimed invention. 48 Lemley, Economics of Improvements, supra note __, at 1010 ("The original patent owner can prevent the improver from using his patented technology, but the improver can also prevent the original patent owner from using the improvement. Unless the parties bargain, no one gets the benefit of the improvement."). 49 See id. at 1013. This power is by no means absolute, and a bargaining breakdown could nullify the benefit of the blocking patent. copying, then there is no improving from the viewpoint of the follow-on inventor. She is, from her perspective, starting from scratch. For the patent system to play a role in improving technology, the base technology the system encourages must be known and used in some way by the improver. If she has not copied, her invention is not an improvement at all, but independent development of a better alternative (a "leapfrogging" invention).
b. Design-Around Theory
The design-around theory is a subset of the improvement theory. The theory is that patent system sparks a specific type of an "improvement"-a substitute to the patented technology that does not infringe the patent. 50 A competitor, faced with the possibility of infringing the patent in order to compete in a given industry, reads the patent in order to determine how they can "design-around" the boundaries of the patent's claims. 51 The patent, by promoting the creation of a commercial substitute through this design-around process, is socially beneficial. 52 The Federal Circuit has acknowledged 50 See Slimfold Mfg. Co. v. Kinkead Indus., Inc., 932 F.2d 1453, 1457 (Fed. Cir. 1991) ("Designing around patents is ... one of the ways in which the patent system works to the advantage of the public in promoting progress in the useful arts, its constitutional purpose."). 51 See Craig A. Nard, 14 Harv. J. L. & Tech. 1, 40-41 (2000) ("As the term 'design-around' suggests, a competitor of the patentee may purposefully circumvent the boundaries of the patent claim and create a competitive, non-infringing alternative to the claimed invention."). 52 Id.
that encouraging design-arounds is a goal of the patent system: "One of the benefits of a patent system is its so-called 'negative incentive' to 'design around' a competitor's products, even when they are patented, thus bringing a steady flow of innovations to the marketplace."
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The design-around theory, like the improvement theory, assumes a level of copying by the competitor who chooses to design around. Here, the theory assumes that the competitor references the patent's claims when designing a competing product. The patent claims are examined with the goal of making sure that the developed product does not fall within the patent's exclusivity. A successful design-around does not copy every element of the claimed technology. But one who designs around an invention necessarily refers to and uses the patented invention in developing the competing product or process.
c. Doctrine of Equivalents Theory
One justification for the doctrine of equivalents also assumes copying by potential infringers. As has already been mentioned, the Supreme Court specifically dismissed evidence of the infringer's copying of the patented invention (or alternatively, of the infringer's efforts to design around the invention) as irrelevant to the doctrine of equivalents inquiry. 54 But the early judicial rationale behind doctrine of equivalents built upon the concepts of fairness and equity to justify the doctrine's existence. 55 The Supreme 58 See Meurer & Nard, supra note __, at 1967-68 (describing the modern "friction theory" of the doctrine of equivalents); Cotropia, supra note __, at 160-62 (noting the current emphasis on a utilitarian theory of the doctrine and a focus on after-arising technologies). 59 See, e.g., Trading Techs. Int'l, Inc. v. eSpeed, Inc., 507 F. Supp. 2d 854, 860-61 (N.D. Ill. 2007) (quoting Graver Tank's copying discussion to describe the "import of the doctrine of equivalents"). often said to have "copied" 60 the invention and, in turn, is labeled a "copier" 61 or "copyist." 62 This terminology is used even when the infringer actually independently developed the infringing product or process. Likewise, an independent invention is often identified as a "copy" of an earlier patent. The infringing product or process is also tagged a "copy" 63 even though technically it was independently created. Such rhetoric even rises to the level of labeling the infringer a "thief" 64 or their actions "stealing" 65 when the infringement was innocent.
The use of the term copying and its derivatives to characterize infringement is notable. Initially, the use of such terms runs contrary to patent law's strict liability, copy- 
C. Reforms to Copying's Role in Patent Law
Finally, a number of commentators and legislators have proposed reforms thatgive copying a larger role patent law. These reforms target copying's role in determining infringement and take the form of various degrees of independent inventor defenses.
In its purest form, an independent inventor defense absolves any patent infringer of liability unless the infringement resulted from copying the claimed invention. That is, "independent conception of the invention and independent reduction of it to practice" Stephen Maurer and Suzanne Scotchmer articulate two advantages to an independent inventor defense. 72 First, the threat of market entry by an independent inventor forces the patent holder to license at a lower price, reducing deadweight loss.
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In addition, the availability of an independent inventor defense also "reduces entry into 74 Id. 75 Id. at 544. 76 Id. at 484-89 (detailing the contours of a such a defense). 77 Id. at 485-87. 78 Id. at 485-86. 79 Id. at 486-87.
be denied the defense because of constructive notice. Vermont argues that such a defense reduces certain "system costs" while not detrimentally lowering the patent system's incentive to invent.
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Not all analysis of an independent inventor defense is positive. One of the authors of this article, while not completely disagreeing with the above analysis, articulated some concerns with the defense. 81 First, the number of significant inventions that have occurred in a multiple, independent inventor setting means that a defense will likely have a significant impact. 82 There is a risk that the availability of the defense will reduce the incentive to invest in important technologies. This is particularly true if the barrier to invention is cost, not the uncertainty of the results. 83 In addition, for certain industries, such as the pharmaceutical industry, "patent owners may need the power associated with a right of compete exclusion not just to encourage invention but to ensure that the inventor invests the resources to take the idea from invention through development to marketability." 84 An independent invention defense would focus the patent system on copying to some extent -absolutely in the case of a pure independent invention defense, and to a lesser extent if Vermont's hybrid proposal were adopted.
85
80 Id. at 493-500. The system costs saved include monopoly losses, rent dissipation, and other miscellaneous costs such as patent prosecution and litigation costs. Id. at 490-93. 81 Lemley, Proof of Copying, supra note __. 82 Id. at 1528 (citing such examples of simultaneous invention as the steamboat, airplane, and laser). 83 Id. at 1529. 84 Id. at 1530-31. 85 Cite Vermont, angel.
II. The Scarcity of Copiers in Patent Cases
Because copying is not an element of patent cases, there is no specific requirement that plaintiffs plead or prove that the defendant has copied the invention, either from the patent itself or from the plaintiff's commercial embodiment of the invention. Nonetheless, there is good reason to believe that plaintiffs will have strong incentives to plead and prove copying in cases where it exists. First, the fact that the defendant copied an invention from the plaintiff strongly suggests that the defendant's overwhelming majority do) 87 naturally want a good story to tell, and the story of theft is much more attractive than the story of inadvertent infringement.
To evaluate whether plaintiffs made claims of copying, we studied complaints for patent infringement. To determine how those allegations fared, we studied written decisions that involve copying. The combined data give us a useful window into the extent of copying in patent litigation.
A. Allegations of Copying
Data Collection
To Because of the liberal patent venue statute, 28 U.S.C. § 1400, patent plaintiffs can usually choose any district in the country to file suit. As a result, the location of plaintiffs or defendants in the district is less important than it is in other types of litigation.
We selected these two districts because they are two of top five districts for patent litigation, and because the IPLC had data for those districts available at an early stage in its collection process. We acknowledge the possibility that different districts might produce different results, though our industry controls and the fact that the districts have such different characteristics should minimize that chance.
PACER data files were corrupted or unavailable, two because they in fact involved only trade secret claims or attempted to file suit on a not-yet-issued patent, and one that involved a design patent. As a result, our data set includes 193 useable cases.
For each of those 193 cases, we collected the initial complaint (if it was filed within our time frame) as well as any amended complaints. We focused on amended complaints because it is possible that plaintiffs did not have evidence of copying when they filed their lawsuit, but later acquired such evidence; if so, it is reasonable to expect that some if not all of them would include that evidence in amended complaints. Our data set includes 179 initial complaints, 69 first amended complaints, 21 second amended complaints, and 8 third or more amended complaints.
Data on Allegations of Willfulness
Of the 193 cases, plaintiffs alleged willfulness in the overwhelming majority:
157, or 81.3%. This is roughly consistent with Kimberly Moore's finding that willfulness was alleged in the overwhelming majority of cases. 89 While one might think that evidence that at least plaintiffs believed copying was widespread, in fact we cannot draw that conclusion, because the legal definition of willfulness at the time these complaints were filed did not require proof of copying or even advance knowledge of the existence of the patent or the patent owner. involved allegations that the defendant was even aware of the patent before the lawsuit.
It is common for patent plaintiffs to send a letter putting the defendant on notice of the existence of the patent; if the plaintiff did in fact send such a letter, we would expect them to allege it, because in most cases patent damages begin to accrue only once the defendant receives such notice. 91 The fact that nearly 70% of plaintiffs don't even allege that the defendant was on notice of the patent at the time the lawsuit was filed suggests that the plaintiffs had no evidence that the defendants in those cases had copied the patent. 92 Further, of the 98 amended complaints in our database, only three were amended to add allegations of willfulness, providing at least some inferential evidence that most claims of willfulness don't involve actual knowledge of the defendant's intent.
Were it otherwise, we would expect to see willfulness pled later in the case rather than at the outset.
a failure to make adequate investigation can still make even an independent developer a willful infringer. 91 If the patentee makes physical products and marks them, that marking may constitute constructive notice of infringement. 35 U.S.C. § 287(a). If they do not mark their products, or if they have a process patent, or if they don't sell products, they can recover damages only for sales that occurred after the patentee gave notice of the patent to the defendant. If there is no marking and no notice, damages are not available except for sales made after the suit is filed. 92 That doesn't mean the defendants in those cases didn't actually copy, of course; just that the plaintiff had no basis on which to allege that they did, even as of the date of filing of the amended complaints.
Data on Allegations of Copying
When we investigated allegations that might correspond to actual copying, the results were even more dramatic. Barely ten percent (21 of 193, or 10.9%) of the complaints we studied alleged that the defendant had copied the invention, either from the patent or from the plaintiff's commercial product. And we might think of this in some respects as an upper bound, because these include bare allegations that the defendant copied the invention. For example, we included in this category an allegation that the defendant has "built their system on use of [plaintiff's] patents" and an allegation that defendants product are "a substantial copy" of plaintiff's, both of which might be general uses of the term "copy" or "use" to refer to similarity rather than derivation. Also notable is the fact that 13 of these 21 cases are pharmaceutical patents filed against generic ANDA filers; because of the Hatch-Waxman Act generic pharmaceutical defendants necessarily must copy the plaintiff's active ingredient to achieve bioequivalence, though this doesn't necessarily mean they copied the patented component of the invention.
The prevalence of ANDA cases in the small subset of cases that allege copying also points up another fact: whether patent plaintiffs allege copying depends significantly on particular industries. In Table 1 , we report not only the overall data on copying but also the industry-specific data. As noted above, 10.9% of the cases overall allege copying. But the percentage of cases that allege copying by industry range from a low of 0% in optics and semiconductors to a high of 65% in pharmaceuticals and 56% in chemistry. 94 It is also worth noting that the two largest classes in our sample, computer-related inventions and software, have extremely low levels of alleged copying (2.6% and 3.0%, respectively).
To try further to parse these allegations of copying, we reviewed the complaints to determine what particular facts were alleged that might support an inference of copying.
We found that ten of the 193 complaints, or 5.2%, involved allegations of a prior business relationship between the firms, something that might plausibly have led to copying. Only five of the 193 complaints, or 2.6%, include an allegation of misappropriation of trade secrets, which necessarily requires an allegation of copying.
And only two cases involve allegations of infringement by departing employees. 95 None of these taken alone is particularly strong evidence; it is certainly possible that a defendant copied the plaintiff's invention in the marketplace or read the patent and used it to design its product, though the latter in particular would seem an odd business decision.
And trade secret claims exist in some tension with patent claims, since one requires secrecy and the other requires disclosure. 96 But these data points reinforce the idea that not merely express allegations of copying, but allegations of facts that might involve copying, are surprisingly rare. 94 To avoid meaningless results, we report in text only the results for those industries with more than ten cases in our sample. 95 These numbers can't merely be added together; the two departing employee cases, for example, are also two of the cases that involve trade secret claims. 96 Finally, it is possible that even where defendants are engaged in copying, the plaintiffs may not know of that copying at the time they file their complaints. To try to assess this, we evaluate changes in allegations to see whether amended complaints add allegations of willfulness or copying. Only two amended complaints add allegations of copying, and only three add allegations of willfulness. While it is of course possible that plaintiffs discovered evidence of copying too late to amend the complaint, or discovered it but decided not to amend the complaint, for the reasons we suggested above we think plaintiffs would likely have been motivated to amend the complaint to add those allegations if possible.
Patent infringement, like most causes of action in the federal system, is governed by the relatively lax rules of notice pleading. 97 As a result, it is possible that plaintiffs simply do not include allegations either of copying or of the facts that might give rise to copying, opting instead for a simple complaint that merely identifies the patent and the defendant's product. As noted above, we think there are substantial reasons to allege copying when the plaintiff has evidence of it. Nonetheless, we acknowledge that the data in this section may undercount the number of cases in which plaintiffs believe defendants have copied their invention, because some of those plaintiffs may simply not have mentioned that fact in their complaints. To guard against this possibility, we collected 102 actual reported decisions that litigate issues that involve evidence of copying. 98 For each of those decisions, we then collected the associated complaints from the Stanford IP Litigation Clearinghouse and ran the same analysis we ran on the randomly selected 97 Fed. R. Civ. P. 8. 98 There were 107 cases collected, but in two cases the files were corrupted and in three cases the complaints were unavailable. We discuss the results of those decisions in the next section.
complaints. This should provide a useful check on the problem of underpleading; if copying is not alleged in these complaints, which ultimately involve litigation of copying issues, it would suggest that our approach might be missing some substantial evidence of copying.
We report the aggregate results in Table 2 . These results largely confirm the validity of using complaint allegations as a measure of copying. Nearly two-thirds of these cases involved allegations of copying, more than six times the number in the randomly-selected data set. Nonetheless, the number is less than 100%, suggesting that at least some cases that involve arguments (though not necessarily evidence) about copying do not have complaints that include those allegations. Complaints may, in other words, somewhat underreport claims of copying because of notice pleading. But even if we modify the data from the random sample to account for this underreporting, 99 the results don't change much: copying allegations rise from 10.9% overall to 16.6% overall, from 2.6% of computer cases to 99 We did this by dividing the number of cases alleging copying in the sampled complaints by 65.7%, the number that alleged it in cases that ultimately involved copying.
4.0%, and from 3.0% to 4.6% of software cases. And remember that these are allegations, and so (as transformed) represent an upper bound on the number of actual cases of copying.
B. Court Findings of Copying
To get further evidence of copying, we turn from complaints to decided cases.
Data Collection
In order to measure actual findings of copying in patent cases, we looked at district court opinions available on WESTLAW.
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We collected an initial set of opinions that included all opinions in cases involving an allegation of patent infringement An allegation of patent infringement included both claims of patent infringement appearing in the complaint and counterclaims of the same. An opinion contained an allegation of patent infringement even if the patent infringement claim had been dismissed or adjudicated prior to the opinion's issuance. Claims of infringement based solely on design patents or plant variety patents were not considered "patent infringement cases" for the purposes of this study. 102 Weighting by cases rather than opinions makes sense so as to not overweight those cases were there are multiple opinions. infringement cases in which opinions were published on WESTLAW during a twenty-six month period.
We then coded the patent infringement opinions for these cases in the following three ways. Opinions mentioning allegations of copying were identified first. 103 We used a liberal approach for identifying allegations of copying, including even bare allegations as instances of alleged copying, looking for assertions that either the patent or a commercial embodiment of the invention was copied. We further investigated opinions that included allegations of copying to determine whether copying was actually proven. 104 A finding of copying for the purposes of this study included only those findings that the patented invention was copied.
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We made a separate pass on the dataset of patent infringement cases to identify cases that involved allegations of willful infringement.
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For those cases containing allegations of willful infringement, we determined whether the allegation was decided, 103 We did this in a two step process. The dataset was searched on WESTLAW to identify discussions of copying. For example, the dataset was searched for the presence of the words "copying," "copied," or "copy" within the same paragraph as the word "patent". Then the results of that search were examined by hand to gain a full understanding of whether the copying of the patented technology, if any, was alleged. In an ANDA case, copying was considered "found" if infringement was found.
105 As contrast, an opinion that found copying of non-patented aspects of the plaintiff's technology was not coded as a finding of copying for the purposes of this study. See, e.g., 106 This was done in a two step process such as the approach taking with the copying coding. The dataset was searched on WESTLAW to identify discussions of willful infringement. For example, the dataset was searched for the presence of any derivative of the string "willful" with three words of the string "infring!". Then, the results of that search were examined by hand to gain a full understanding of the willful infringement, if any, that was actually alleged.
and if so, whether willful infringement was found or not.
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We also coded the willfulness cases by industry.
108
A final search of the patent infringement dataset was done to identify all opinions mentioning allegations of infringement based on filings of an ANDA-that is infringement under 35 U.S.C. § 271(e)(2)(A).
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2.
Data on Claims of Copying
Out of the 1871 patent infringement opinions in the dataset, 129 of them (6.89%)
included an allegation of copying that was mentioned in an opinion. Of these 129 cases, the allegation of copying was based on the filing of an ANDA in a little over half of the cases-78 (60.47%) of the cases. 110 Copying was actually found in 33 cases (25.58%),
with the finding occurring in 22 of the ANDA cases and 11 of the non-ANDA cases.
When placed in the context of all of the patent infringement cases in the study, copying was established in only 1.76% of all cases in the dataset.
A couple of observations can be made. First, the percentage of cases where copying was alleged dropped from 10.9% when we looked at the complaints to 6.89% among opinions. This drop may reflect the fact that a district court has little reason in many cases to mention copying in a written opinion. For example, some decisions that 107 For example, an allegation of willfulness was deemed "decided" if the opinion reported a jury verdict, bench trial determination, ruling on a judgment as a matter of law, or decision on summary judgment. 108 The same categories used in the early part of this article were used here. See supra note 105.
109 Again, the process was initially done by searching on WESTLAW-for example searching for the strings "ANDA" or "abbreviated new drug application"-and then, processing those results by hand. 110 All ANDA cases were coded as cases alleging copying due to the nature of the § 271(e)(2)(A) claim. However, it is worth repeating, the copying necessary for filing an ANDA is may not be copying of the patented technology.
involve claims of copying may not need to resolve the copying issue, and therefore may not discuss it. Second, the fact that a little over half of the copying allegations and twothirds of the findings of copying occurred in ANDA cases is explained by the nature of the ANDA patent litigation. This falls in line with the data from complaints, with around 60% of cases alleging copying both in complaints and opinions. As previously explained, ANDA cases inherently involve copying of the patentee's product by the alleged infringer, and in most such cases the copying is of the patented technology. 111 And when infringement is found, that infringement generally means that the patented invention was copied in the ANDA.
Finally, and probably most noteworthy, is the very small number of cases where copying is actually found. Such findings make up just over one percent of the cases included in this part of our study. And if the ANDA cases are removed because of their unique linkage to copying, findings of copying drop to less then half a percent. The percentage of actual findings of copying may be low, but there is also a real possibility of underreporting. As much as patentees want to allege copying, and it is in their interest to do so, there is typically no reason for a court to mention copying in a patent infringement opinion because copying is irrelevant to the core issue in these cases-liability. In fact, district courts are encouraged to ignore copying in their opinions given that the Federal Circuit admonished courts before for discussing copying in the context of patent infringement. 
3.
Data on Willful Infringement Findings
An alternative way to determine the amount of copying that actually takes place in patent infringement cases is to focus on those patent infringement cases where copying is explicitly relevant to the opinion being written. In opinions discussing patent issues where copying is relevant-in willfulness or nonobviousness decisions for example-a court is more likely to be presented with evidence of copying and, in turn, more likely to mention and decide the question of copying the patent. The law makes copying relevant in these contexts and therefore a litigant's push to make copying an issue is more likely to be reflected in a written opinion. At the same time, just considering these cases would overstate the amount of copying, since copying is by definition far more likely to be raised in those cases than in the litigation population at large.
As a result, we focused on cases involving allegations of willful infringement-an area of patent law where copying is highly relevant and very likely to be alleged if the facts make copying available. 113 In the dataset, there were 226 cases (12.08%) were an allegation of willful infringement was mentioned.
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An allegation of copying was mentioned or implied in 40 (17.70%) of these cases. 115 A decision on willfulness was reported in 77 cases (34.07%) of the 226 cases. The split in results on willfulness was 113 See supra. 114 The much lower percentage of cases where there was an allegation of willfulness as compared to the complaint data is explained by the fact that a district court has no reason to mention an allegation of willful infringement unless the allegation is being decided. And the issue of willfulness is not addressed until most of the other issues in a given case are resolved in the patentee's favor. Therefore, in the opinion data, there is likely significant underreporting of willfulness allegations. 115 As before, patent infringement claims based on the filing of ANDAs are treated as allegations of copying of the patented technology. The low percentages, however, still tell the same story as our earlier analysissurprisingly little copying has occurred in these litigated cases.
It is also worth noting that when a court decides the willfulness issue and also finds copying, the court deems the infringement willful. This data suggests that actual copying is good evidence of willful infringement. The one case in which copying did not This data mimics the results from complaint data in all respects except one. As with complaints, pharmaceutical and chemistry cases make up a large portion of those cases mentioning allegations of copying and finding actual copying. On the other end of the spectrum are computer-related and software, where there was a large number of cases alleging willful infringement, but a small number of allegations and findings of copying.
The exception is the prevalence of copying in mechanical cases relative to the complaint data. Mechanical cases came in a close third behind pharmaceutical and chemical cases in allegations of copying and pulled well ahead of these two classes in actual findings of copying, with 7 findings compared to 3 for both pharmaceutical and chemical. While the complaint data could not code for actual findings of copying, the complaint data did capture allegations and there were not nearly as large a percentage in mechanical cases as there are in the case data.
C. Interpreting the Data
None of these measures is perfect. Data based on complaints are in one sense likely to overstate the amount of copying, since it merely requires that the plaintiff allege something even in general terms, not that it be proven. On the other hand, it may well understate the amount of copying, because some plaintiffs may not include an allegation of copying even if they believe it to have occurred, or may find out about copying too late in the litigation to amend their complaints. The specific fact situations we associate with copying are similarly both under-and over-inclusive; not every case of a departing employee or a business deal gone bad will involve copying, and not every case of copying will involve one of those facts.
Data based on actual litigation of willfulness in written decisions reflects a different set of biases; it solves the undercounting and mistaken allegations problems with complaints, but it overcounts bench as opposed to jury trials, since the former are more likely to result in a written opinion, and it may be subject to selection bias if obvious cases of copying are disproportionately likely to settle before resolution.
If each of these measures produced significantly different results, we might conclude that those results reflected imperfections in the proxies we used for copying.
But the fact that all these diverse methodologies produce largely consistent results gives us substantial confidence that copying is indeed rare in patent litigation.
III. Implications of the Data
A. Understanding Policy Debates and Reform Proposals
The rarity of copying in modern patent law has several implications for understanding current rhetorical debates, public policy discussions, and proposals for reform.
First, it should be evident that patent infringement can rarely, if ever, be equated with "theft" of physical property or even "piracy" of other types of IP. Public policy debates around patent reform often involve claims that any weakening of the patent right will destroy the patent system by encouraging widespread "theft" of patent rights. 122 But our data suggest that there is very little "theft" of patent rights going on right now.
Virtually every case filed -and even the overwhelming majority of those in which the plaintiffs win and claim that the defendant was a willful infringer -involve not theft or even copying with a legitimate effort to design around but independent development by the defendant. That doesn't mean that they are not infringing, or that they shouldn't be held liable. Nor does it resolve the underlying debates over patent reform; just because no one is copying patented inventions now doesn't mean they wouldn't do so under a different legal regime. But it is simply inaccurate to speak of patent defendants as a whole as "unscrupulous copyists" or "thieves." Our data provides a significant new piece of evidence to support that view. The IT industries, which faced a majority of the lawsuits in our samples, were virtually never accused of actually copying their products from the patent owner. Their perspective on strong patent enforcement rules will accordingly be quite different than that of companies in an industry in which copying is the norm in infringement suits.
Finally, our data shed some light on the growing chorus of calls for an independent development defense. A number of scholars have argued that patent law should exempt independent development and instead target only copying, just as copyright and trade secret law do. 125 One of us has expressed some skepticism over that proposal. 126 Our data demonstrates precisely how much is at stake in this debate. A patent infringement system that punished only copying would look dramatically different than current law. Ninety percent of patent lawsuits would go away, and most patent litigation would be in the chemical and pharmaceutical industries. Some will suggest this would be a good idea. 127 We express no opinion on that issue here, other than to point out precisely how different such a patent system would be from the one we have today.
B. Calibrating Patent Damages
Our findings bear on one significant set of judicial and policy debates -those over the appropriate measure of damages in patent infringement cases. Unlike copyright and trade secret law, which provide that prevailing plaintiffs can recover not only for their own losses but also the defendant's gains, 128 are not making a calculated decision whether to infringe a patent. The overwhelming majority of defendants are independent developers who were unaware of the existence of the patent when they made their product design decisions. And those who were aware of the patent and made a decision to infringe are mostly generic pharmaceutical companies subject to a special set of rules that make the application of reasonable royalty law implausible in the extreme. 138 Less than 4% of complaints in our database involve even allegations of copying that might justify a deterrence-related "kicker" 139 of the sort that is increasingly showing up in Federal Circuit case law. For the same reason, the scholarship that suggests treating the "choice" to infringe as a real option for which the infringer should have to pay 140 misses the point: overwhelmingly, infringers are not choosing to infringe, but are designing products in ways that are later found to infringe.
141
138 In pharmaceutical patent cases, the generic must notify the patentee before selling a generic product, and the patentee is entitled to an automatic 30-month stay of those sales pending its infringement suit. 21 U.S.C. § 355(j)(B)(iv); § 355(j)(5)(B)(iii). If that 30-month period expires, courts can enter preliminary injunctions, and even if they don't generic companies are often afraid to enter the market "at risk." As a result, most pharmaceutical patent cases never involve claims of damages at all. And if they do, those damages will almost certainly be the patent owner's lost profits, not a reasonable royalty, since by hypothesis the generic has copied a drug the patent owner is currently selling on the market. 139 Panduit Corp. v. Stahlin Bros. Fibre Works, Inc., 575 F.2d 1152 (6 th Cir. 1978) established the concept of a "kicker" to account for otherwise-uncompensated losses. The Federal Circuit rejected the kicker idea in Mahurkar v. C.R. Bard co., 79 F.3d 1572, 1580 (Fed. Cir. 1996) (no "kicker" is permissible on top of the reasonable royalty to compensate for attorney's fees or litigation expenses; patentee must prove case is exceptional to recover such expenses), but has reimported it under other names. See, e.g., King Instruments Corp. v. Perego, 65 F.3d 941, 951 n.6 (Fed. Cir. 1995) ("discretionary increases"); Stickle v. Heublein, Inc., 716 F.2d 1550, 1563 (Fed. Cir. 1983) (allowing for "an increase in the reasonable royalty determined by the court"). 140 Hausman et al., supra note __; J. Gregory Sidak, Holdup, Royalty Stacking, and the Presumption of Injunctive Relief for Patent Infringement, 92 Minn. L. Rev. 714 (2008) . 141 To be sure, one could envision a market in which patents were easy to identify, interpret, and license, and in such a hypothetical world it might make sense to require all companies to search We aren't suggesting that damages aren't appropriate for patent infringement; far from it. But deterrence and unjust enrichment are concepts designed to punish and therefore discourage infringement; they have no place in a patent regime where virtually all infringement is unintentional.
In the rare cases where infringement is intentional, patent law provides for treble damages for willful infringement. 142 A second finding in our data, though, is that "willfulness" as the term is used in patent law bears little resemblance to intentional copying. that preceded it. It remains to be seen whether this new standard will bring claims of willfulness more in line with the subset of cases involving claims of intentional conduct.
C. Patents and Technology Transfer
Our data may also shed some light on the role of the patent system in encouraging technology transfer. The patent cases we studied were not, by and large, cases about a defendant learning the invention from the plaintiff. That doesn't mean that technology transfer from patentees to others doesn't happen in the patent system, of course. We expect that patent licensing involves technology transfer (as opposed to merely an agreement to forebear from suit) in a wide variety of contexts, from university licenses to start-ups to joint ventures to international outsourcing of production. 145 But it does suggest that patent litigation today is not about policing failed efforts at technology transfer, but rather about efforts by patent owners to enforce their right of exclusivity or to collect revenue from independent creators. As a corollary, it may well be that judicial or legislative efforts to curb abuse of patent litigation will have no significant adverse effect on the technology transfer function of the patent system, though it is important to make sure that efforts to limit the very real problem of litigation abuse don't spill over into attacks on patent rights more generally.
Our data do provide some inferential support for those who have argued that the disclosure function of the patent system isn't working terribly well. A variety of evidence already suggests that scientists in most industries rarely read patents, and that even if they did those patents aren't a particularly good means of conveying technical information. 146 The fact that few if any people appear to be copying technology from patent owners is consistent with this argument, though it is not proof that people aren't copying inventions after the expiration of their patents.
IV. Conclusion
Patents are fundamentally different from other types of IP rights. The patent litigation system does not appear to operate to prevent copying, instead giving patent owners control primarily over independent invention by third parties. There may be good reasons to give patent owners this control, whether to give inventors extra incentives or perhaps to create more certain rights that more easily can be licensed. But debates over the patent system -and legal rules that set remedies for infringement -should not be based on the assumption that patent infringers are "thieves" or "copiers." The evidence we offer in that paper suggests that that assumption is wrong.
